Your session is about to expire
← Back to Search
ALTO-100 PO Tablet for Depression
Study Summary
This trial will help researchers understand how safe and effective ALTO-100 is for people with Alzheimer's disease.
- Depression
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the age limit for enrollment into this clinical trial greater than 65?
"This medical research is open to applicants aged 18 years or older and younger than 65."
What is the eligibility criteria for participants in this research?
"This medical trial requires individuals suffering from major depressive disorder to be admitted, with the age requirement being between 18 and 64. The number of participants needed for this experiment is approximately 50."
How reliable is ALTO-100 PO Tablet in terms of patient safety?
"Based on prior clinical data, ALTO-100 PO Tablet's safety has been evaluated as a 2. As this is only a phase two trial, there are some indications of safety but no evidence yet for efficacy."
Is this research recruitment still open?
"This medical experiment is not currently recruiting, after being first posted on June 1st 2022 and its most recent update occuring October 21st 2022. Nevertheless, there are presently 1295 other trials actively seeking participants."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger